Cephalon, Inc.

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Cephalon, Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Cephalon, Inc.

Cephalon, Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by RITUXIMAB-ABBS. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: adult patients, positive b-cell, previously untreated, nhl single, rheumatoid arthritis, polyangiitis gpa, wegener granulomatosis, pemphigus vulgaris. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
RITUXIMAB-ABBS 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — INTRAVENOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Cephalon, Inc.

Brand nameGenericTypeRoute
Truxima RITUXIMAB-ABBS HUMAN PRESCRIPTION DRUG INTRAVENOUS

Frequently asked questions

How many FDA drug products does Cephalon, Inc. make?
1 FDA drug label records name Cephalon, Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Cephalon, Inc. produce?
The most frequent active ingredients in this portfolio are RITUXIMAB-ABBS.

Are Cephalon, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.